Basic Information | Post buying leads | Suppliers |
IUPAC Name: [(7S,8R)-7-[(Z)-2-Methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate
Molecular Formula: C21H33NO7
Molecular Weight: 411.55g/mol
Freely Rotating Bonds: 12
Polar Surface Area: 83.53 Å2
Index of Refraction: 1.544
Molar Refractivity: 106.91 cm3
Molar Volume: 338.2 cm3
Polarizability: 42.38 ×10-24cm3
Surface Tension: 49.7 dyne/cm
Density: 1.21 g/cm3
Flash Point: 268.1 °C
Enthalpy of Vaporization: 91.21 kJ/mol
Boiling Point: 519.8 °C at 760 mmHg
Vapour Pressure: 5.63E-13 mmHg at 25°C
The Cas Register Number of Lasiocarpine is 303-34-4 .The chemical synonyms of Lasiocarpine (CAS No. 303-34-4) are Lasiocarpine ; 2-Butenoic acid, 2-methyl-, 7[[(2,3-dihydroxy-2-(1-methoxyethyl)-3-methyl-1-oxobutoxy] methyl]-2,3,5,7a-tetrahydro-1h-prrolizin-1-yl ester, [1s-[1alpha(z), 7(2s*, 3r*), 7aalpha)]- ; (Z)-2-Methyl-2-butenoic acid (1s)-7-[[[(2r)-2,3-dihydroxy-2-[(s)-1-methoxyethyl]-3-methylbutanoyl]oxy]methyl]-2,3,5,7aβ-tetrahydro-1h-pyrrolizin-1-yl ester .The molecular structure of Lasiocarpine (CAS No. 303-34-4) is.
1. | sln-dmg-orl 750 ppm | ENMUDM Environmental Mutagenesis. 7 (1985),349. | ||
2. | trn-dmg-orl 750 ppm | ENMUDM Environmental Mutagenesis. 7 (1985),349. | ||
3. | orl-rat TDLo:255 mg/kg/2Y-C:CAR | NCITR* National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD 20014) No. NCI-CG-TR-39 ,1978. | ||
4. | ipr-rat TDLo:470 mg/kg/56W-I:CAR | CNREA8 Cancer Research. 32 (1972),908. | ||
5. | orl-rat LD50:110 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 17 (1970),290. | ||
6. | ipr-rat LD50:78 mg/kg | CNREA8 Cancer Research. 32 (1972),908. | ||
7. | ivn-rat LD50:88 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 126 (1959),179. | ||
8. | par-rat LD50:80 mg/kg | NATUAS Nature. 223 (1969),1269. | ||
9. | ivn-mus LDLo:85 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 126 (1959),179. | ||
10. | ivn-mky LDLo:20 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 126 (1959),179. |
IARC Cancer Review: Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 , 1976,p. 281.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . NCI Carcinogenesis Bioassay (feed); No Evidence: mouse, rat NCITR* National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD 20014) No. NCI-CG-TR-39 ,1978. . EPA Genetic Toxicology Program.
Suspected carcinogen with experimental carcinogenic data. Poison by ingestion, intravenous, intraperitoneal, and parenteral routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. See also ESTERS.
RIDADR: 1544
HazardClass: 6.1(b)
PackingGroup: III